Related Experiment Video
Updated: Jan 23, 2026

Haptic/Graphic Rehabilitation: Integrating a Robot into a Virtual Environment Library and Applying it to Stroke Therapy
Published on: August 8, 2011
Antiplatelet Therapy After Noncardioembolic Stroke
Jacoba P Greving1, Hans-Christoph Diener2, Johannes B Reitsma1
1From the Julius Center for Health Sciences and Primary Care (J.P.G., J.B.R., A.A.).
For secondary prevention after noncardioembolic stroke, clopidogrel and aspirin/dipyridamole combination are effective and safe. Aspirin/clopidogrel combination increases major bleeding risk, particularly in younger patients.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Secondary prevention of noncardioembolic stroke and transient ischemic attack (TIA) is crucial.
- Antiplatelet agents are commonly prescribed, but their comparative efficacy and safety profiles require detailed assessment.
- Patient characteristics may influence treatment outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of different antiplatelet agents for long-term secondary prevention after noncardioembolic stroke or TIA.
- To examine how treatment effects vary based on patient demographic and clinical factors.
Main Methods:
- A network meta-analysis (NMA) of 6 randomized trials involving 43,112 patients.
- Individual patient data were pooled and reanalyzed.
- Outcomes included serious vascular events, major bleeding, and net clinical benefit, with subgroup analyses performed.
Main Results:
- Aspirin/dipyridamole and clopidogrel significantly reduced vascular events compared to aspirin alone.
- Clopidogrel demonstrated a lower risk of major bleeding and intracranial hemorrhage.
- Aspirin/clopidogrel combination showed a higher risk of major bleeding, especially in patients under 65.
Conclusions:
- Clopidogrel and aspirin/dipyridamole combination are favored for long-term secondary stroke prevention, irrespective of patient characteristics.
- Aspirin/clopidogrel combination is associated with increased major bleeding risk.
- Treatment choice should consider individual patient profiles and bleeding risks.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Gene Therapy
Group Therapy
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Psychodynamic Therapy
Humanistic Therapy

